Literature DB >> 12928843

Significance of serum atrial and brain natriuretic peptide release after coronary artery bypass grafting.

Masazumi Watanabe1, Koso Egi, Satoru Hasegawa, Hiroyuki Tanaka, Hisanaga Ohshima, Tohru Sakamoto, Makoto Sunamori.   

Abstract

PURPOSE: The aim of this study was to examine whether serial changes in endogenous levels of brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) were associated with clinical status after coronary artery bypass grafting (CABG).
METHODS: Serial blood samples were collected from 14 patients preoperatively, 2, 5 and 8 h after cardiopulmonary bypass, then up to 7 days postoperatively. Follow-up was done 2 years later.
RESULTS: We found a significant increase from the preoperative values in ANP and BNP concentrations on postoperative days 1 and 3 (P < 0.001). The elevated BNP concentration correlated with the preoperative values (r2 = 0.824, P = 0.0005). Retrospectively, the BNP concentrations after surgery in the patients who suffered cardiac events within 2 years were significantly higher than those in the patients free of cardiac events (P = 0.0023).
CONCLUSION: The BNP concentration after CABG was found to be corrected with interim clinical status after surgery. Thus, it may be necessary for patients with a high postoperative BNP concentration to be closely monitored for coronary events.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928843     DOI: 10.1007/s00595-003-2580-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  2 in total

Review 1.  Practical application of human B-type natriuretic peptide as a therapeutic intervention in the perioperative setting.

Authors:  David S Feldman; Benjamin Sun
Journal:  Heart Fail Rev       Date:  2004-07       Impact factor: 4.214

2.  Changes in N-terminal pro B-type natriuretic peptide concentration: comparative study of percutaneous transluminal coronary angioplasty and off-pump coronary artery bypass graft.

Authors:  Hyun Koo Kim; Hark Jei Kim; Jin Won Kim; Young-sang Sohn; Young Ho Choi
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.